These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 17662396)

  • 21. Electroanatomic substrate and outcome of catheter ablative therapy for ventricular tachycardia in setting of right ventricular cardiomyopathy.
    Marchlinski FE; Zado E; Dixit S; Gerstenfeld E; Callans DJ; Hsia H; Lin D; Nayak H; Russo A; Pulliam W
    Circulation; 2004 Oct; 110(16):2293-8. PubMed ID: 15477406
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ablation of ventricular arrhythmias in arrhythmogenic right ventricular dysplasia.
    Arbelo E; Josephson ME
    J Cardiovasc Electrophysiol; 2010 Apr; 21(4):473-86. PubMed ID: 20132399
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical outcomes of catheter ablation of ventricular tachycardia in patients with arrhythmogenic right ventricular cardiomyopathy: Insights from the Johns Hopkins ARVC Program.
    Daimee UA; Assis FR; Murray B; Tichnell C; James CA; Calkins H; Tandri H
    Heart Rhythm; 2021 Aug; 18(8):1369-1376. PubMed ID: 33933674
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outcome of cardiac sarcoidosis after radiofrequency ablation and placement of AICD- A propensity matched analysis.
    Bandyopadhyay D; Sahoo D; Zein J; Brunken RC; Tchou PJ; Culver DA
    Sarcoidosis Vasc Diffuse Lung Dis; 2015 Jun; 32(1):70-9. PubMed ID: 26237358
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical features of arrhythmogenic right ventricular dysplasia/cardiomyopathy associated with mutations in plakophilin-2.
    Dalal D; Molin LH; Piccini J; Tichnell C; James C; Bomma C; Prakasa K; Towbin JA; Marcus FI; Spevak PJ; Bluemke DA; Abraham T; Russell SD; Calkins H; Judge DP
    Circulation; 2006 Apr; 113(13):1641-9. PubMed ID: 16549640
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epicardial ventricular tachycardia ablation a multicenter safety study.
    Sacher F; Roberts-Thomson K; Maury P; Tedrow U; Nault I; Steven D; Hocini M; Koplan B; Leroux L; Derval N; Seiler J; Wright MJ; Epstein L; Haissaguerre M; Jais P; Stevenson WG
    J Am Coll Cardiol; 2010 May; 55(21):2366-72. PubMed ID: 20488308
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serial reevaluation for ARVD/C is indicated in patients presenting with left bundle branch block ventricular tachycardia and minor ECG abnormalities.
    Kiès P; Bootsma M; Bax JJ; Zeppenfeld K; van Erven L; Wijffels MC; van der Wall EE; Schalij MJ
    J Cardiovasc Electrophysiol; 2006 Jun; 17(6):586-93. PubMed ID: 16836703
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Irrigated radiofrequency catheter ablation guided by electroanatomic mapping for recurrent ventricular tachycardia after myocardial infarction: the multicenter thermocool ventricular tachycardia ablation trial.
    Stevenson WG; Wilber DJ; Natale A; Jackman WM; Marchlinski FE; Talbert T; Gonzalez MD; Worley SJ; Daoud EG; Hwang C; Schuger C; Bump TE; Jazayeri M; Tomassoni GF; Kopelman HA; Soejima K; Nakagawa H;
    Circulation; 2008 Dec; 118(25):2773-82. PubMed ID: 19064682
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Electroanatomic mapping of the endocardium. Implication for catheter ablation of ventricular tachycardia.
    Wetzel U; Hindricks G; Dorszewski A; Schirdewahn P; Gerds-Li JH; Piorkowski C; Kobza R; Tanner H; Kottkamp H
    Herz; 2003 Nov; 28(7):583-90. PubMed ID: 14689118
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Natural history and risk stratification of arrhythmogenic right ventricular dysplasia/cardiomyopathy.
    Hulot JS; Jouven X; Empana JP; Frank R; Fontaine G
    Circulation; 2004 Oct; 110(14):1879-84. PubMed ID: 15451782
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lack of uniform progression of endocardial scar in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy and ventricular tachycardia.
    Riley MP; Zado E; Bala R; Callans DJ; Cooper J; Dixit S; Garcia F; Gerstenfeld EP; Hutchinson MD; Lin D; Patel V; Verdino R; Marchlinski FE
    Circ Arrhythm Electrophysiol; 2010 Aug; 3(4):332-8. PubMed ID: 20558846
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Radiofrequency catheter ablation of ventricular tachycardia].
    Fontaine G; Frank R; Gallais Y; Rosás Andrade F; Tonet J; Lascault G; Aouate P; Poulain F
    Arch Mal Coeur Vaiss; 1996 Feb; 89 Spec No 1():99-107. PubMed ID: 8734170
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of clinical and procedural predictors on ventricular tachycardia ablation outcomes: an analysis from the substrate mapping and ablation in Sinus Rhythm to Halt Ventricular Tachycardia Trial (SMASH-VT).
    Tung R; Josephson ME; Reddy V; Reynolds MR;
    J Cardiovasc Electrophysiol; 2010 Jul; 21(7):799-803. PubMed ID: 20132389
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Noninvasive detection of myocardial fibrosis in arrhythmogenic right ventricular cardiomyopathy using delayed-enhancement magnetic resonance imaging.
    Tandri H; Saranathan M; Rodriguez ER; Martinez C; Bomma C; Nasir K; Rosen B; Lima JA; Calkins H; Bluemke DA
    J Am Coll Cardiol; 2005 Jan; 45(1):98-103. PubMed ID: 15629382
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Arrhythmogenic right ventricular dysplasia: a United States experience.
    Dalal D; Nasir K; Bomma C; Prakasa K; Tandri H; Piccini J; Roguin A; Tichnell C; James C; Russell SD; Judge DP; Abraham T; Spevak PJ; Bluemke DA; Calkins H
    Circulation; 2005 Dec; 112(25):3823-32. PubMed ID: 16344387
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Late clinical outcome after radiofrequency catheter ablation of idiopathic ventricular tachycardia: follow-up study.
    Petrac D; Radić B; Vukosavić D; Birtić K
    Croat Med J; 2002 Feb; 43(1):20-4. PubMed ID: 11828553
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Catheter ablation reduces ventricular tachycardia burden in patients with arrhythmogenic right ventricular cardiomyopathy: insights from a north-western French multicentre registry.
    Souissi Z; Boulé S; Hermida JS; Doucy A; Mabo P; Pavin D; Anselme F; Auquier N; Ninni S; Coisne A; Brigadeau F; Deken-Delannoy V; Klug D; Lacroix D
    Europace; 2018 Feb; 20(2):362-369. PubMed ID: 28017936
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term follow-up and risk assessment of arrhythmogenic right ventricular dysplasia/cardiomyopathy: personal experience from different primary and tertiary centres.
    Peters S
    J Cardiovasc Med (Hagerstown); 2007 Jul; 8(7):521-6. PubMed ID: 17568286
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New ECG criteria in arrhythmogenic right ventricular dysplasia/cardiomyopathy.
    Cox MG; van der Smagt JJ; Wilde AA; Wiesfeld AC; Atsma DE; Nelen MR; Rodriguez LM; Loh P; Cramer MJ; Doevendans PA; van Tintelen JP; de Bakker JM; Hauer RN
    Circ Arrhythm Electrophysiol; 2009 Oct; 2(5):524-30. PubMed ID: 19843920
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Arrhythmogenic right ventricular cardiomyopathy. Antiarrhythmic drugs, catheter ablation, or ICD?
    Wichter T; Paul TM; Eckardt L; Gerdes P; Kirchhof P; Böcker D; Breithardt G
    Herz; 2005 Mar; 30(2):91-101. PubMed ID: 15875097
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.